tiprankstipranks
Myriad Genetics (MYGN)
NASDAQ:MYGN
Holding MYGN?
Track your performance easily

Myriad Genetics (MYGN) Financial Statements

359 Followers

Myriad Genetics Financial Overview

Myriad Genetics's market cap is currently ―. The company's EPS TTM is $-1.299; its P/E ratio is -11.54; Myriad Genetics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $0.03. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 213.30M$ 211.50M$ 202.20M$ 196.60M$ 191.90M
Gross Profit$ 149.80M$ 147.10M$ 137.60M$ 135.00M$ 134.30M
EBIT$ -21.20M$ -37.20M$ -25.40M-$ -60.20M
EBITDA$ -3.30M$ -20.00M$ -7.40M-$ -46.10M
Net Income Common Stockholders$ -22.10M$ -35.90M$ -26.00M$ -31.20M$ -61.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 99.90M$ 97.30M$ 104.30M$ 140.90M$ 86.30M
Total Assets$ 1.08B$ 1.09B$ 1.11B$ 1.15B$ 1.15B
Total Debt$ 143.10M$ 143.30M$ 146.80M$ 152.10M$ 201.40M
Net Debt$ 43.20M$ 46.00M$ 42.50M$ 11.20M$ 115.10M
Total Liabilities$ 349.60M$ 344.60M$ 350.50M$ 363.30M$ 465.70M
Stockholders Equity$ 731.70M$ 740.50M$ 760.00M$ 783.20M$ 683.40M
Cash Flow-
Free Cash Flow$ -2.80M$ -2.60M$ -25.30M-$ -39.60M
Operating Cash Flow$ 700.00K$ 2.60M$ -18.60M$ -54.70M$ -22.10M
Investing Cash Flow$ 7.50M$ -6.40M$ -7.10M$ -12.00M$ -2.50M
Financing Cash Flow$ -3.10M$ 2.40M$ -8.80M$ 121.90M$ -2.50M
Currency in USD

Myriad Genetics Earnings and Revenue History

Myriad Genetics Debt to Assets

Myriad Genetics Cash Flow

Myriad Genetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis